跳至主要内容
临床试验/NCT06839157
NCT06839157进行中(未招募)不适用

An Artificial Intelligence - Assisted Model for Predicting Optimal Timing of Surgery in Advanced Ovarian Cancer: the Combined Study of the SUNNY Trial and the Real World Data

Shanghai Gynecologic Oncology Group0 个研究点目标入组 1,025 人开始时间: 2016年8月22日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
1,025
主要终点
The accuracy of predicting the 3-year overall survival (OS) difference between primary debulking surgery (PDS) and interval debulking surgery (IDS).

研究概览

简要总结

This study integrates data from the randomized controlled SUNNY trial (RCT) and real-world (RWD) data, and employs multimodal data fitting to construct a medical artificial intelligence model to identify the clinical characteristics of patient subgroups suitable for primary debulking surgery (PDS) or interval debulking surgery (IDS), and the cutoff values for selecting different timings of surgery for advanced ovarian cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Age ≥ 18 years
  • •Patients who were included in the SUNNY study or who were newly diagnosed with stage IIIC or IV primary epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer during the SUNNY study period (2015-2023)
  • •Underwent primary debulking surgery or interval debulking surgery
  • •Data avaliable on first-line treatment and follow-up

排除标准

  • •Non-epithelial ovarian cancer or borderline tumors.
  • •Low-grade tumors.
  • •Mucinous ovarian cancer.
  • •Missing data on first-line treatment and follow-up

研究组 & 干预措施

Cohort 2- Pragmatic Trial

536 patients who were newly diagnosed as stage IIIC or IV primary epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer between 2021 and 2025

Cohort 1- SUNNY RCT Trial

489 patients who were enrolled and randomized in the SUNNY RCT trials.

结局指标

主要结局

The accuracy of predicting the 3-year overall survival (OS) difference between primary debulking surgery (PDS) and interval debulking surgery (IDS).

时间窗: 3 years

次要结局

未报告次要终点

研究者

发起方
Shanghai Gynecologic Oncology Group
申办方类型
Other Gov
责任方
Sponsor

相似试验